1,840
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Substantial inter-individual variations in insulin secretion and sensitivity across the glucometabolic spectrum

, , ORCID Icon, , , , , & show all
Pages 282-290 | Received 15 Aug 2019, Accepted 09 Feb 2020, Published online: 05 Mar 2020

References

  • Ferrannini E, Mari A. Beta cell function and its relation to insulin action in humans: a critical appraisal. Diabetologia. 2004;47(5):943–956.
  • Eckel RH, Alberti KG, Grundy SM, et al. The metabolic syndrome. Lancet. 2010;375(9710):181–183.
  • Ferrannini E, Gastaldelli A, Miyazaki Y, et al. Beta-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab. 2005;90(1):493–500.
  • Marchetti P, Lupi R, Del Guerra S, et al. The beta-cell in human type 2 diabetes. Adv Exp Med Biol. 2010;654:501–514.
  • Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes. 1993;42(11):1663–1672.
  • Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 2002;106:3143–3421.
  • Shaw DI, Tierney AC, McCarthy S, et al. LIPGENE food-exchange model for alteration of dietary fat quantity and quality in free-living participants from eight European countries. Br J Nutr. 2008;101(5):750–759.
  • Tierney AC, McMonagle J, Shaw DI, et al. Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome–LIPGENE: a European randomized dietary intervention study. Int J Obes. 2011;35(6):800–809.
  • Gulseth HL, Gjelstad IMF, Tiereny AC, et al. Effects of dietary fat on insulin secretion in subjects with the metabolic syndrome. Eur J Endocrinol. 2019;180(5):321–328.
  • Wium C, Gulseth HL, Eriksen EF, et al. Characteristics of glucose metabolism in Nordic and South Asian subjects with type 2 diabetes. PLoS One. 2013;8(12):e83983.
  • Gulseth HL, Wium C, Angel K, et al. Effects of vitamin D supplementation on insulin sensitivity and insulin secretion in subjects with type 2 diabetes and vitamin D deficiency: a randomized controlled trial. Diabetes Care. 2017;40(7):872–878.
  • Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487–1495.
  • Pacini G. The hyperbolic equilibrium between insulin sensitivity and secretion. Nutrition, metabolism, and cardiovascular diseases. NMCD. 2006;16:S22–S27.
  • Ahren B, Pacini G. Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies. Eur J Endocrinol. 2004;150:97–104.
  • Clausen JO, Borch-Johnsen K, Ibsen H, et al. Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. J Clin Invest. 1996;98(5):1195–1209.
  • Martin BC, Warram JH, Krolewski AS, et al. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet. 1992;340(8825):925–929.
  • Lillioja S, Mott DM, Spraul M, et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med. 1993;329(27):1988–1992.
  • Hollenbeck C, Reaven GM. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab. 1987;64(6):1169–1173.
  • Allemann Y, Horber FF, Colombo M, et al. Insulin sensitivity and body fat distribution in normotensive offspring of hypertensive parents. Lancet. 1993;341(8841):327–331.
  • Osei K, Cottrell DA, Orabella MM. Insulin sensitivity, glucose effectiveness, and body fat distribution pattern in nondiabetic offspring of patients with NIDDM. Diabetes Care. 1991;14(10):890–896.
  • Bardet S, Pasqual C, Maugendre D, et al. Inter and intra individual variability of acute insulin response during intravenous glucose tolerance tests. Diabetes Metab. 1989;15(5):224–232.
  • Clinical Diabetes Research: Methods and techniques. Chichester: John Wiley & Sons, Ltd; 2007.
  • Mari A, Tura A, Pacini G, et al. Relationships between insulin secretion after intravenous and oral glucose administration in subjects with glucose tolerance ranging from normal to overt diabetes. Diabet Med. 2008;25(6):671–677.
  • Ahlqvist E, Storm P, Karajamaki A, et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018;6:361–369.
  • Zaharia OP, Strassburger K, Strom A, et al. Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. Lancet Diabetes Endocrinol. 2019;7:684–694.
  • Stidsen JV, Henriksen JE, Olsen MH, et al. Pathophysiology-based phenotyping in type 2 diabetes: a clinical classification tool. Diabetes Metab Res Rev. 2018;34(5):e3005.